Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery

Crit Care Med. 2006 Aug;34(8):2134-9. doi: 10.1097/01.CCM.0000227647.77356.AB.

Abstract

Objective: Cytokine response after cardiac surgery may be genetically influenced. A study was carried out to investigate the relation between cytokine gene expression in peripheral blood mononuclear cells, genotype, and clinical events after cardiac surgery.

Design: A case-control study was performed.

Setting: Cardiac intensive care unit in a university hospital.

Subjects: A total of 82 patients having elective cardiac surgery were divided into those having uncomplicated recovery (n = 48) or recovery complicated by hyperlactatemia or requirement for inotropic support (n = 34).

Interventions: The relative change in peripheral blood mononuclear cell tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) messenger RNA 1 and 6 hrs after cardiopulmonary bypass was compared with a baseline preoperative level using quantitative reverse transcriptase polymerase chain reaction. DNA was analyzed for carriage of TNF-alpha and IL-10 polymorphic alleles.

Measurements and main results: Cardiopulmonary bypass was longer in duration in the complicated group. TNF-alpha gene expression decreased and IL-10 gene expression increased in peripheral blood mononuclear cells after surgery when compared with preoperative levels. One hour after cardiopulmonary bypass, the complicated group had more TNF-alpha and less IL-10 messenger RNA production than the uncomplicated group. The IL-10/TNF-alpha ratio was greater in uncomplicated than in complicated recovery patients. An IL-10 haplotype was identified that was less frequent in the complicated group. There was no difference between groups in TNF-alpha genotype. On multivariate analysis, cardiopulmonary bypass time and the IL-10/TNF-alpha messenger RNA ratio were independent predictors of outcome.

Conclusions: There is a predominant anti-inflammatory cytokine response after uneventful cardiac surgery. IL-10 may have a protective role after cardiac surgery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cardiopulmonary Bypass*
  • Cardiotonic Agents / therapeutic use
  • Case-Control Studies
  • Female
  • Gene Expression*
  • Haplotypes
  • Humans
  • Intensive Care Units
  • Interleukin-10 / genetics*
  • Lactic Acid / blood
  • Leukocytes, Mononuclear / metabolism*
  • Male
  • Multivariate Analysis
  • Postoperative Complications / blood
  • Postoperative Complications / drug therapy
  • Postoperative Period
  • Preoperative Care
  • Prospective Studies
  • RNA, Messenger / metabolism
  • Time Factors
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Cardiotonic Agents
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Lactic Acid